Related Experiment Video
Updated: Jul 28, 2026
09:02
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Primary hepatic leiomyosarcoma
H Holloway1, C B Walsh, R Thomas
1Department of Medicine, Royal College of Surgeons, Dublin, Ireland.
Journal of Clinical Gastroenterology
|September 1, 1996
Summary
A rare hepatic leiomyosarcoma was diagnosed in a patient with chronic pulmonary disease. Despite extensive investigation, the primary tumor source remained unidentified, leading to conservative management.
Area of Science:
- Oncology
- Hepatology
- Pathology
Background:
- Chronic pulmonary disease exacerbations can present with diverse systemic manifestations.
- Hepatomegaly, or enlarged liver, requires thorough etiological investigation.
- Leiomyosarcoma is a rare soft tissue sarcoma with potential for diverse presentations.
Observation:
- A 63-year-old male presented with worsening chronic pulmonary disease.
- Physical examination revealed hepatomegaly.
- Fine needle aspiration biopsy confirmed the presence of hepatic leiomyosarcoma.
Findings:
- The hepatic tumor was diagnosed as leiomyosarcoma.
- Extensive diagnostic workup, including imaging and laboratory tests, did not identify a primary tumor origin.
- The patient's underlying pulmonary condition was considered in the management strategy.
Implications:
- This case highlights the importance of considering rare liver malignancies in patients with unexplained hepatomegaly.
- The absence of a detectable primary source for hepatic leiomyosarcoma presents diagnostic and therapeutic challenges.
- Conservative management may be indicated in select cases, balancing risks and benefits.
